Elongation of C. elegans embryos appears to be driven by microfilament dependent cell shape changes in the hypodermis (1). Several mutations in
let-502 have been identified that lead to arrest during early embryonic elongation (2,3). We have cloned
let-502 and found that it encodes a serine/threonine kinase with significant similarity to a group of recently identified kinases activated by the binding of small G-proteins (Rho/Rac) and to human myotonic dystrophy kinase.
let-502 mutations can be genetically suppressed by lf mutations in
mel-11. We cloned
mel-11 and identified its similarity to smooth muscle myosin phosphatase regulatory subunits. We propose a model in which binding of Rho activates LET-502, which in turn inhibits the activity of a smooth muscle-like myosin phosphatase complex via phosphorylation of MEL-11. This inactivation of the phosphatase complex leads to actin-myosin contraction resulting in the cell shape changes necessary for embryonic elongation (3). We have recently obtained evidence that MEL-11 interacts genetically with Rho or a similar G-protein. Double mutants of
mel-11 and
unc-73, a suspected Rho guanine nucleotide exchange factor, suggest that Rho may have a direct activating effect on MEL-11. We have also conducted a genetic screen for
mel-11 suppressors resulting in a number of candidates that may define additional components in this small G-protein mediated pathway. 1 Priess, J.R. & Hirsh, D.L. Developmental Biology 117, 156-173 (1986) 2 Howell, A.M. & Rose, A.M. Genetics 126, 583-592 (1990) 3 Wissmann et al. Genes & Development 11, 409-422 (1997)